Global Cardiac Biomarkers Market to Reach US$ 21.0 Billion by 2032, Facilitated by Increasing Prevalence of Heart Diseases

November 28, 2022 | Healthcare

IMARC Group’s latest report, titled “Cardiac Biomarkers Market Report by Type (Troponins (T and I), Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Others), Location of Testing (Laboratory Testing, Point of Care Testing), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), and Region 2024-2032,” finds that the global cardiac biomarkers market size reached US$ 10.7 Billion in 2023. Cardiac biomarkers refer to endogenous substances released in the circulation when the heart is stressed or damaged. These substances comprise various enzymes, hormones, and proteins, such as myoglobin, troponin, creatine kinase, and ischemia-modified albumin. They can be detected in the bloodstream and act as a potential tool to diagnose heart diseases, such as cardiac ischemia and acute coronary syndrome (ACS). They assist in analyzing heart function, monitoring the prognosis of these conditions with higher precision, and providing the most effective treatment to patients. As a result, cardiac biomarker testing is gaining immense traction across the healthcare industry due to its accuracy and ability to identify diseases in their early stages. 

Global Cardiac Biomarkers Market Trends:

The increasing prevalence of heart diseases due to sedentary lifestyles, changing dietary patterns, and unhealthy habits, such as excessive smoking and alcohol consumption, represents the primary factor driving the market growth. Besides this, high accuracy and rapid results offered by cardiac biomarker testing are acting as other major growth-inducing factors. Moreover, the escalating demand for point-of-care (POC) cardiac testing kits in nursing homes and home healthcare owing to their cost effectiveness and during emergencies for faster diagnosis has accelerated product adoption rates. Additionally, there has been a substantial rise in funding from public and private organizations for research and development (R&D) activities on cardiac biomarkers. In line with this, several favorable initiatives by governments of various countries to improve the accessibility of healthcare services have catalyzed market growth. Furthermore, the leading players are introducing innovative product variants such as multi-assay biomarkers. Along with this, the launch of numerous high-sensitivity troponin assays that aid in detecting the protein quickly and at relatively lower levels compared to conventional troponin tests has propelled the market growth. These biomarkers also assist in identifying the risk of future cardiac problems like heart attacks in individuals with no symptoms. Other factors, including the aging population, surging awareness regarding the importance of early disease diagnosis, improving healthcare infrastructure, and ongoing technological advancements, are also providing a positive thrust to the market growth. Looking forward, IMARC Group expects the market value to reach US$ 21.0 Billion by 2032, expanding at a CAGR of 7.6% during 2024-2032.

Market Summary:

  • Based on the type, the market has been categorized into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNP) or NT-proBNP, ischemia modified albumin (IMA) and others. Amongst these, troponins (T and I) represent the largest market segment.
  • On the basis of the location of testing, the market has been bifurcated into laboratory and point of care testing. At present, laboratory testing accounts for the majority of the market share. 
  • The market has been segmented based on the application into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. Presently, myocardial infarction exhibits a clear dominance in the market.
  • Region-wise, North America holds the leading position in the market. Other major regions include Asia Pacific, Europe, Middle East and Africa, and Latin America.
  • The competitive landscape of the market has also been analyzed, with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson and Co., Biomerieux SA, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare, and Thermo Fisher Scientific.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N Gould St, Ste 
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Cardiac Biomarkers Market to Reach US$ 21.0 Billion by 2032, Facilitated by Increasing Prevalence of Heart Diseases
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More